WST logo

WST Cash from financing

annual CFF:

-$622.60M-$163.00M(-35.47%)
December 31, 2024

Summary

  • As of today (May 31, 2025), WST annual cash flow from financing activities is -$622.60 million, with the most recent change of -$163.00 million (-35.47%) on December 31, 2024.
  • During the last 3 years, WST annual CFF has fallen by -$454.50 million (-270.37%).
  • WST annual CFF is now -616.68% below its all-time high of $120.50 million, reached on December 31, 2005.

Performance

WST Cash from financing Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Range

Earnings dates

OtherWSTcash flow metrics

quarterly CFF:

-$147.00M-$78.10M(-113.35%)
March 31, 2025

Summary

  • As of today (May 31, 2025), WST quarterly cash flow from financing activities is -$147.00 million, with the most recent change of -$78.10 million (-113.35%) on March 31, 2025.
  • Over the past year, WST quarterly CFF has increased by +$124.00 million (+45.76%).
  • WST quarterly CFF is now -212.47% below its all-time high of $130.70 million, reached on March 31, 2007.

Performance

WST quarterly CFF Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Range

Earnings dates

OtherWSTcash flow metrics

TTM CFF:

-$498.60M+$124.00M(+19.92%)
March 31, 2025

Summary

  • As of today (May 31, 2025), WST TTM cash flow from financing activities is -$498.60 million, with the most recent change of +$124.00 million (+19.92%) on March 31, 2025.
  • Over the past year, WST TTM CFF has increased by +$161.00 million (+24.41%).
  • WST TTM CFF is now -513.78% below its all-time high of $120.50 million, reached on December 31, 2005.

Performance

WST TTM CFF Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Range

Earnings dates

OtherWSTcash flow metrics

Cash from financing Formula

CFF = Cash Inflows from Financing Activities − Cash Outflows from Financing Activities

WST Cash from financing Trends

PeriodPeriodAnnualAnnualQuarterlyQuarterlyTTMTTM
1 y1 year-35.5%+45.8%+24.4%
3 y3 years-270.4%+14.9%-170.4%
5 y5 years-1591.8%-22.2%-648.6%

WST Cash from financing Highs & Lows

PeriodPeriodAnnual vs highAnnual vs highAnnual vs lowAnnual vs lowQuarter. vs highQuarter. vs highQuarter. vs lowQuarter. vs lowTTM vs highTTM vs highTTM vs lowTTM vs low
3 y3-year-270.4%at low-1447.4%+45.8%-170.4%+32.9%
5 y5-year-1591.8%at low<-9999.0%+45.8%-648.6%+32.9%
alltimeall time-616.7%at low-212.5%+45.8%-513.8%+32.9%

WST Cash from financing History

DateAnnualQuarterlyTTM
Mar 2025
-
-$147.00M(+113.4%)
-$498.60M(-19.9%)
Dec 2024
-$622.60M(+35.5%)
-$68.90M(+7.0%)
-$622.60M(-16.2%)
Sep 2024
-
-$64.40M(-70.5%)
-$743.20M(+6.0%)
Jun 2024
-
-$218.30M(-19.4%)
-$701.10M(+6.3%)
Mar 2024
-
-$271.00M(+43.0%)
-$659.60M(+43.5%)
Dec 2023
-$459.60M(+56.5%)
-$189.50M(+749.8%)
-$459.60M(+64.4%)
Sep 2023
-
-$22.30M(-87.4%)
-$279.60M(-15.9%)
Jun 2023
-
-$176.80M(+149.0%)
-$332.50M(+73.3%)
Mar 2023
-
-$71.00M(+647.4%)
-$191.90M(-34.6%)
Dec 2022
-$293.60M(+74.7%)
-$9.50M(-87.4%)
-$293.60M(+1.1%)
Sep 2022
-
-$75.20M(+107.7%)
-$290.30M(+31.4%)
Jun 2022
-
-$36.20M(-79.0%)
-$220.90M(+19.8%)
Mar 2022
-
-$172.70M(+2685.5%)
-$184.40M(+9.7%)
Dec 2021
-$168.10M(+22.6%)
-$6.20M(+6.9%)
-$168.10M(-1.5%)
Sep 2021
-
-$5.80M(-2033.3%)
-$170.60M(-0.8%)
Jun 2021
-
$300.00K(-100.2%)
-$172.00M(-0.7%)
Mar 2021
-
-$156.40M(+1697.7%)
-$173.20M(+26.3%)
Dec 2020
-$137.10M(+272.6%)
-$8.70M(+20.8%)
-$137.10M(+77.1%)
Sep 2020
-
-$7.20M(+700.0%)
-$77.40M(+9.6%)
Jun 2020
-
-$900.00K(-99.3%)
-$70.60M(+6.0%)
Mar 2020
-
-$120.30M(-335.9%)
-$66.60M(+81.0%)
Dec 2019
-$36.80M(-54.4%)
$51.00M(<-9900.0%)
-$36.80M(-61.7%)
Sep 2019
-
-$400.00K(-112.9%)
-$96.00M(+12.3%)
Jun 2019
-
$3.10M(-103.4%)
-$85.50M(-25.2%)
Mar 2019
-
-$90.50M(+1003.7%)
-$114.30M(+41.6%)
Dec 2018
-$80.70M(-26.0%)
-$8.20M(-181.2%)
-$80.70M(-49.2%)
Sep 2018
-
$10.10M(-139.3%)
-$159.00M(-7.6%)
Jun 2018
-
-$25.70M(-54.8%)
-$172.10M(+19.4%)
Mar 2018
-
-$56.90M(-34.2%)
-$144.10M(+32.2%)
Dec 2017
-$109.00M(-4.3%)
-$86.50M(+2783.3%)
-$109.00M(+122.9%)
Sep 2017
-
-$3.00M(-230.4%)
-$48.90M(-19.7%)
Jun 2017
-
$2.30M(-110.6%)
-$60.90M(-13.7%)
Mar 2017
-
-$21.80M(-17.4%)
-$70.60M(-38.0%)
Dec 2016
-$113.90M(+174.5%)
-$26.40M(+76.0%)
-$113.90M(+27.8%)
Sep 2016
-
-$15.00M(+102.7%)
-$89.10M(-14.7%)
Jun 2016
-
-$7.40M(-88.6%)
-$104.50M(-3.1%)
Mar 2016
-
-$65.10M(+3968.8%)
-$107.80M(+159.8%)
Dec 2015
-$41.50M(+34.7%)
-$1.60M(-94.7%)
-$41.50M(-0.5%)
Sep 2015
-
-$30.40M(+184.1%)
-$41.70M(+95.8%)
Jun 2015
-
-$10.70M(-991.7%)
-$21.30M(-61.8%)
Mar 2015
-
$1.20M(-166.7%)
-$55.80M(+81.2%)
Dec 2014
-$30.80M(+503.9%)
-$1.80M(-82.0%)
-$30.80M(-41.3%)
Sep 2014
-
-$10.00M(-77.9%)
-$52.50M(+33.2%)
Jun 2014
-
-$45.20M(-272.5%)
-$39.40M(+14.5%)
Mar 2014
-
$26.20M(-211.5%)
-$34.40M(+574.5%)
Dec 2013
-$5.10M(+50.0%)
-$23.50M(-858.1%)
-$5.10M(-54.1%)
Sep 2013
-
$3.10M(-107.7%)
-$11.10M(+70.8%)
Jun 2013
-
-$40.20M(-172.4%)
-$6.50M(-123.3%)
Mar 2013
-
$55.50M(-288.1%)
$27.90M(-920.6%)
Dec 2012
-$3.40M(-86.2%)
-$29.50M(-483.1%)
-$3.40M(+70.0%)
Sep 2012
-
$7.70M(-232.8%)
-$2.00M(-44.4%)
Jun 2012
-
-$5.80M(-124.0%)
-$3.60M(+500.0%)
Mar 2012
-
$24.20M(-186.1%)
-$600.00K(-97.6%)
Dec 2011
-$24.70M(-27.4%)
-$28.10M(-560.7%)
-$24.70M(+120.5%)
Sep 2011
-
$6.10M(-317.9%)
-$11.20M(-47.9%)
Jun 2011
-
-$2.80M(-2900.0%)
-$21.50M(-23.2%)
Mar 2011
-
$100.00K(-100.7%)
-$28.00M(-17.6%)
Dec 2010
-$34.00M(+50.4%)
-$14.60M(+247.6%)
-$34.00M(-7.9%)
Sep 2010
-
-$4.20M(-54.8%)
-$36.90M(-0.5%)
Jun 2010
-
-$9.30M(+57.6%)
-$37.10M(+5.7%)
Mar 2010
-
-$5.90M(-66.3%)
-$35.10M(+55.3%)
Dec 2009
-$22.60M(-23.1%)
-$17.50M(+297.7%)
-$22.60M(+43.9%)
Sep 2009
-
-$4.40M(-39.7%)
-$15.70M(-0.6%)
Jun 2009
-
-$7.30M(-210.6%)
-$15.80M(-44.8%)
Mar 2009
-
$6.60M(-162.3%)
-$28.60M(-2.7%)
Dec 2008
-$29.40M(-134.8%)
-$10.60M(+135.6%)
-$29.40M(-23.6%)
Sep 2008
-
-$4.50M(-77.6%)
-$38.50M(-37.6%)
Jun 2008
-
-$20.10M(-446.6%)
-$61.70M(+53.1%)
Mar 2008
-
$5.80M(-129.4%)
-$40.30M(-147.6%)
Dec 2007
$84.60M
-$19.70M(-28.9%)
$84.60M(-15.8%)
Sep 2007
-
-$27.70M(-2230.8%)
$100.50M(-8.6%)
DateAnnualQuarterlyTTM
Jun 2007
-
$1.30M(-99.0%)
$109.90M(+36.5%)
Mar 2007
-
$130.70M(-3539.5%)
$80.50M(-233.7%)
Dec 2006
-$60.20M(-150.0%)
-$3.80M(-79.2%)
-$60.20M(+58.8%)
Sep 2006
-
-$18.30M(-34.9%)
-$37.90M(-4.8%)
Jun 2006
-
-$28.10M(+181.0%)
-$39.80M(-133.7%)
Mar 2006
-
-$10.00M(-154.1%)
$118.20M(-1.9%)
Dec 2005
$120.50M(-882.5%)
$18.50M(-191.6%)
$120.50M(+25.0%)
Sep 2005
-
-$20.20M(-115.6%)
$96.40M(-19.8%)
Jun 2005
-
$129.90M(-1787.0%)
$120.20M(-9346.2%)
Mar 2005
-
-$7.70M(+37.5%)
-$1.30M(-91.6%)
Dec 2004
-$15.40M(+27.3%)
-$5.60M(-255.6%)
-$15.40M(0.0%)
Sep 2004
-
$3.60M(-57.1%)
-$15.40M(-34.2%)
Jun 2004
-
$8.40M(-138.5%)
-$23.40M(-20.7%)
Mar 2004
-
-$21.80M(+289.3%)
-$29.50M(+143.8%)
Dec 2003
-$12.10M(-63.3%)
-$5.60M(+27.3%)
-$12.10M(-17.7%)
Sep 2003
-
-$4.40M(-291.3%)
-$14.70M(-30.3%)
Jun 2003
-
$2.30M(-152.3%)
-$21.10M(-30.4%)
Mar 2003
-
-$4.40M(-46.3%)
-$30.30M(-8.2%)
Dec 2002
-$33.00M(+108.9%)
-$8.20M(-24.1%)
-$33.00M(-39.4%)
Sep 2002
-
-$10.80M(+56.5%)
-$54.50M(+45.3%)
Jun 2002
-
-$6.90M(-2.8%)
-$37.50M(+15.4%)
Mar 2002
-
-$7.10M(-76.1%)
-$32.50M(+105.7%)
Dec 2001
-$15.80M(-241.1%)
-$29.70M(-579.0%)
-$15.80M(-190.8%)
Sep 2001
-
$6.20M(-426.3%)
$17.40M(+1.2%)
Jun 2001
-
-$1.90M(-119.8%)
$17.20M(+352.6%)
Mar 2001
-
$9.60M(+174.3%)
$3.80M(-66.1%)
Dec 2000
$11.20M(+30.2%)
$3.50M(-41.7%)
$11.20M(+646.7%)
Sep 2000
-
$6.00M(-139.2%)
$1.50M(-122.7%)
Jun 2000
-
-$15.30M(-190.0%)
-$6.60M(-123.7%)
Mar 2000
-
$17.00M(-374.2%)
$27.90M(+224.4%)
Dec 1999
$8.60M(-145.3%)
-$6.20M(+195.2%)
$8.60M(-360.6%)
Sep 1999
-
-$2.10M(-110.9%)
-$3.30M(-46.8%)
Jun 1999
-
$19.20M(-934.8%)
-$6.20M(-85.1%)
Mar 1999
-
-$2.30M(-87.3%)
-$41.70M(+119.5%)
Dec 1998
-$19.00M(+167.6%)
-$18.10M(+262.0%)
-$19.00M(+726.1%)
Sep 1998
-
-$5.00M(-69.3%)
-$2.30M(-215.0%)
Jun 1998
-
-$16.30M(-179.9%)
$2.00M(-87.0%)
Mar 1998
-
$20.40M(-1557.1%)
$15.40M(-316.9%)
Dec 1997
-$7.10M(-75.4%)
-$1.40M(+100.0%)
-$7.10M(-61.2%)
Sep 1997
-
-$700.00K(-75.9%)
-$18.30M(-30.7%)
Jun 1997
-
-$2.90M(+38.1%)
-$26.40M(+3.5%)
Mar 1997
-
-$2.10M(-83.3%)
-$25.50M(-11.8%)
Dec 1996
-$28.90M(-165.8%)
-$12.60M(+43.2%)
-$28.90M(+27.9%)
Sep 1996
-
-$8.80M(+340.0%)
-$22.60M(+35.3%)
Jun 1996
-
-$2.00M(-63.6%)
-$16.70M(-178.8%)
Mar 1996
-
-$5.50M(-12.7%)
$21.20M(-51.7%)
Dec 1995
$43.90M(+404.6%)
-$6.30M(+117.2%)
$43.90M(-22.3%)
Sep 1995
-
-$2.90M(-108.1%)
$56.50M(-7.2%)
Jun 1995
-
$35.90M(+108.7%)
$60.90M(+152.7%)
Mar 1995
-
$17.20M(+173.0%)
$24.10M(+177.0%)
Dec 1994
$8.70M(-181.3%)
$6.30M(+320.0%)
$8.70M(-293.3%)
Sep 1994
-
$1.50M(-266.7%)
-$4.50M(-35.7%)
Jun 1994
-
-$900.00K(-150.0%)
-$7.00M(-20.5%)
Mar 1994
-
$1.80M(-126.1%)
-$8.80M(-17.8%)
Dec 1993
-$10.70M(-43.1%)
-$6.90M(+590.0%)
-$10.70M(+64.6%)
Sep 1993
-
-$1.00M(-63.0%)
-$6.50M(-47.2%)
Jun 1993
-
-$2.70M(+2600.0%)
-$12.30M(-25.5%)
Mar 1993
-
-$100.00K(-96.3%)
-$16.50M(-12.2%)
Dec 1992
-$18.80M(-3.1%)
-$2.70M(-60.3%)
-$18.80M(-21.3%)
Sep 1992
-
-$6.80M(-1.4%)
-$23.90M(-4.0%)
Jun 1992
-
-$6.90M(+187.5%)
-$24.90M(+14.7%)
Mar 1992
-
-$2.40M(-69.2%)
-$21.70M(+11.9%)
Dec 1991
-$19.40M(+351.2%)
-$7.80M(0.0%)
-$19.40M(+50.4%)
Sep 1991
-
-$7.80M(+110.8%)
-$12.90M(+48.3%)
Jun 1991
-
-$3.70M(+3600.0%)
-$8.70M(+210.7%)
Mar 1991
-
-$100.00K(-92.3%)
-$2.80M(-34.9%)
Dec 1990
-$4.30M(-38.6%)
-$1.30M(-63.9%)
-$4.30M(+43.3%)
Sep 1990
-
-$3.60M(-263.6%)
-$3.00M(-600.0%)
Jun 1990
-
$2.20M(-237.5%)
$600.00K(-137.5%)
Mar 1990
-
-$1.60M
-$1.60M
Dec 1989
-$7.00M
-
-

FAQ

  • What is West Pharmaceutical Services annual cash flow from financing activities?
  • What is the all time high annual CFF for West Pharmaceutical Services?
  • What is West Pharmaceutical Services annual CFF year-on-year change?
  • What is West Pharmaceutical Services quarterly cash flow from financing activities?
  • What is the all time high quarterly CFF for West Pharmaceutical Services?
  • What is West Pharmaceutical Services quarterly CFF year-on-year change?
  • What is West Pharmaceutical Services TTM cash flow from financing activities?
  • What is the all time high TTM CFF for West Pharmaceutical Services?
  • What is West Pharmaceutical Services TTM CFF year-on-year change?

What is West Pharmaceutical Services annual cash flow from financing activities?

The current annual CFF of WST is -$622.60M

What is the all time high annual CFF for West Pharmaceutical Services?

West Pharmaceutical Services all-time high annual cash flow from financing activities is $120.50M

What is West Pharmaceutical Services annual CFF year-on-year change?

Over the past year, WST annual cash flow from financing activities has changed by -$163.00M (-35.47%)

What is West Pharmaceutical Services quarterly cash flow from financing activities?

The current quarterly CFF of WST is -$147.00M

What is the all time high quarterly CFF for West Pharmaceutical Services?

West Pharmaceutical Services all-time high quarterly cash flow from financing activities is $130.70M

What is West Pharmaceutical Services quarterly CFF year-on-year change?

Over the past year, WST quarterly cash flow from financing activities has changed by +$124.00M (+45.76%)

What is West Pharmaceutical Services TTM cash flow from financing activities?

The current TTM CFF of WST is -$498.60M

What is the all time high TTM CFF for West Pharmaceutical Services?

West Pharmaceutical Services all-time high TTM cash flow from financing activities is $120.50M

What is West Pharmaceutical Services TTM CFF year-on-year change?

Over the past year, WST TTM cash flow from financing activities has changed by +$161.00M (+24.41%)
On this page